Search results for "Placental abruption"

showing 3 items of 3 documents

CD15 immunostaining improves placental diagnosis of fetal hypoxia

2020

Fetal hypoxic events with unclear predictive value are a common indication for placenta examination. We evaluated whether the use of CD15 immunostaining can improve the assessment of severity and duration of fetal hypoxia.We compared placentas (37-42 gestational weeks) from stillborns/newborns with birth asphyxia (BA) and non-hypoxic newborns. Placental findings were studied in following groups: (1) acute BA (n = 11) due to placental abruption, (2) non-acute BA (n = 121) due to non-acute conditions, (3) non-BA (n = 46) in pregnancies with preeclampsia and gestational diabetes, and (4) controls (n = 30).A high expression of CD15 in feto-placental resistance vessels (FRVs) was present in non-…

AdultPlacentaPlacental FindingLewis X AntigenIntrauterine hypoxiaFetal HypoxiaPreeclampsiaAndrologyPre-EclampsiaPregnancyPlacentaHumansMedicineRetrospective StudiesAsphyxiaFetusPlacental abruptionbusiness.industryInfant NewbornObstetrics and Gynecologymedicine.diseaseImmunohistochemistryGestational diabetesmedicine.anatomical_structureReproductive Medicineembryonic structuresFemalemedicine.symptombusinessDevelopmental BiologyPlacenta
researchProduct

Anti-fetal immune response mechanisms may be involved in the pathogenesis of placental abruption

2003

Placental abruption is an unpredictable severe complication in pregnancy. In order to investigate the possibility that the activation of the fetal nonadaptive immune system may be involved in the pathogenesis of this disease, IL-6 release from cord blood monocytes was examined by intracellular cytokine staining and flow cytometric analysis. Our results demonstrate that preterm placental abruption (n = 15) in contrast to uncontrollable preterm labor (n = 33) is associated with significantly (P < 0.001) increased release of IL-6 from the fetal monocytes. The same holds true for rhesus disease (n = 9, P < 0.001) that is characterized by a maternal production of antibodies against the rhesus-D …

Time FactorsImmunologyAntibodiesMonocytesPreeclampsiaPathogenesisFetusObstetric Labor PrematureImmune systemHLA AntigensPregnancyHumansImmunology and AllergyMedicineAbruptio PlacentaeFetusPregnancybiologyPlacental abruptionbusiness.industryImmunityFetal Bloodmedicine.diseaseFetal circulationImmunologybiology.proteinFemaleAntibodybusinessClinical Immunology
researchProduct

Predicting adverse obstetric outcome after early pregnancy events and complications: a review.

2009

BACKGROUND The aim was to evaluate the impact of early pregnancy events and complications as predictors of adverse obstetric outcome. METHODS We conducted a literature review on the impact of first trimester complications in previous and index pregnancies using Medline and Cochrane databases covering the period 1980-2008. RESULTS Clinically relevant associations of adverse outcome in the subsequent pregnancy with an odds ratio (OR) > 2.0 after complications in a previous pregnancy are the risk of perinatal death after a single previous miscarriage, the risk of very preterm delivery (VPTD) after two or more miscarriages, the risk of placenta praevia, premature preterm rupture of membranes, V…

medicine.medical_specialtyPopulationRisk AssessmentCrown-Rump LengthMiscarriageHyperemesis gravidarumPregnancyRecurrent miscarriagemedicineBirth WeightHumanseducationreproductive and urinary physiologyPregnancyeducation.field_of_studyPlacental abruptionObstetricsbusiness.industryPregnancy OutcomeObstetrics and GynecologyAbortion Inducedmedicine.diseasePrognosisPregnancy ComplicationsLow birth weightPregnancy Trimester FirstReproductive MedicineApgar scoreFemalemedicine.symptombusinessHuman reproduction update
researchProduct